期刊文献+

人羊膜间充质细胞对异体外周血淋巴细胞的免疫抑制作用

Immunosuppression of human amniotic mesenchymal cells on allogeneic peripheral blood lymphocytes
原文传递
导出
摘要 目的探讨人羊膜间充质细胞(human amniotic mesenchymal cells,hAMCs)对异体外周血淋巴细胞的免疫抑制作用,阐明人羊膜间充质细胞调节移植免疫排斥的作用机制。方法从新鲜足月剖宫产废弃咱勺羊膜组织分离出hAMCs并进行鉴定。采用密度梯度离心从健康志愿者外周血中分离出单个核淋巴细胞(PBMLs),在植物血凝素(PHA)刺激下,分别按1:0.05,1:0.10,1:0.20的比例以hAMCs处理,MTS法检测淋巴细胞的增殖,ELISA法检测细胞因子IFN.1、TNF-α的分泌。结果hAMCs能明显抑制异体外周血淋巴细胞的增殖,hAMCs与PBMLs比值为0.05:1,0.10:1,0.20:1时的增殖抑制率分别为16.91%、20.83%、28.19%。hAMCs还可显著抑制异体淋巴细胞IFN-1和TNF-α的分泌(P〈0.01),并且在一定范围内随着hAMCs数量的增加抑制作用更加明显。结论hAMCs能抑制异体淋巴细胞增殖并降低淋巴细胞IFN-γ和TNF-α的分泌,这可能是其预防和减轻移植排斥反应发生的机制之一。 Objective To explore the immunoregulatory effects of human amniotic mesenchymal cells (hAMCs) on allogeneie peripheral blood lymphoeytes. Methods The hAMCs were isolated from abandoned human amnion. Peripheral blood mononuclear lymphocytes (PBMLs) were separated from healthy donors by density gradient eentrifugation. Then, PBMLs were treated with phytohemagglutinin (PHA) and different concentrations of hAMCs. Proliferation effect of PBMLs was tested using MTS assay, and production of IFN-γ and TNF-α by PBMLs was detected by ELISA. Results hAMCs could remarkably inhibit the lymphocytes proliferation. When the ratios of hAMCs to PBMLs were 0. 05: 1, 0. 10 : 1, 0.20: 1, the inhibitory rates of PBMLs proliferation were 16.91%, 20.83% and 28.19%, respectively. HAMCs also decreased the production of IFN-γ and TNF-αby PBMLs in a dose-dependent manner (P 〈0. 01). Conclusions HAMCs could inhibit the proliferation of allogeneic lymphocytes and reduce secretion of IFN-γand TNF-α, which might be one of the mechanism for prevention and remission of transplant rejection.
出处 《中华整形外科杂志》 CAS CSCD 北大核心 2012年第2期127-130,共4页 Chinese Journal of Plastic Surgery
基金 中日友好医院院级课题(2010-QN-28)
关键词 人羊膜间充质细胞 淋巴细胞 免疫抑制 Human amniotic mesenchymal cells Lymphocytes Immunosuppression
  • 相关文献

参考文献13

  • 1Kim J,Kang HM,Kim H. Ex vivo characteristics of human amniotic membrane-derived stem cells[J].Clon Stem Cells,2007,(04):581-594.doi:10.1089/clo.2007.0027.
  • 2Bailo M,Soncini M,Vertua E. Engraftment potential of human amnion and chorion cells derived from term placenta[J].Transplantation,2004,(10):1439-1448.doi:10.1097/01.TP.0000144606.84234.49.
  • 3Moon JH,Lee JR,Jee BC. Successful vitrification of human amnion-derived mesenchymal stem cells[J].Human Reproduction,2008,(08):1760-1770.doi:10.1093/humrep/den202.
  • 4Banas RA,Trumpower C,Bentlejewski C. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells[J].Human Immunology,2008,(06):321-328.doi:10.1016/j.humimm.2008.04.007.
  • 5胡景伟,蔡哲,周忠蜀,张岚,舒峻,潘琳,黄小杰,徐波,向青,贺春,徐杨,高艳,崔晓慧.体外培养人羊膜间充质细胞的神经生物学特点[J].中国康复医学杂志,2009,24(12):1070-1073. 被引量:5
  • 6Kehua Zhang,Zhe Cai,Yang Li. Utilization of human amniotic mesenchymal cells as feeder layers to sustain propagation of human embryonic stem cells in the undifferentiated state[J].Cell Reprogram,2011,(04):281-288.
  • 7Tamagawa T,Ishiwata I,Ishikawa H. Induced in vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells[J].Human Cell,2008,(02):38-45.doi:10.1111/j.1749-0774.2008.00049.x.
  • 8Minagawa T,Imamura T,Igawa Y. Differentiation of smooth muscle cells from human amaiotic mesenchymal cells implanted in the freeze-injured mouse urinary bladder[J].European Urology,2010,(02):299-306.doi:10.1016/j.eururo.2009.12.031.
  • 9Kadam SS,Sudhakar M,Nair PD. Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immunoisolatory macroeapsules[J].Cytotherapy,2010,(08):982-991.doi:10.3109/14653249.2010.509546.
  • 10蔡哲,周忠蜀,向青,胡景伟,潘琳,张岚,舒峻,徐波,梁妍,左萍萍,贺春,徐杨,高艳,崔晓慧.人羊膜间充质细胞的神经生物学特性及其治疗帕金森模型小鼠的实验研究[J].中国康复理论与实践,2010,16(4):318-321. 被引量:7

二级参考文献25

  • 1WU Zhi-yuan,HUI Guo-zhen,LU Yi,WU Xin,GUO Li-he.Transplantation of human amniotic epithelial cells improves hindlimb function in rats with spinal cord injury[J].Chinese Medical Journal,2006(24):2101-2107. 被引量:23
  • 2Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchyrnal stem cells. Science, 1999, 284:143-147.
  • 3Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Cur Opin Hematol, 2000,7 : 358-363.
  • 4Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 2001, 19:180-192.
  • 5Markus H Frank, Mohamed H Sayegh. Immunomodulatory functions of mesenchymal stem cells. The Lancet, 2004, 363:1411-1413.
  • 6Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003, 102: 3837-3844.
  • 7Cortesini R, Le Maoult J, Ciubotariu R, et al. CID8^+ CD28^- T suppressor cells and the induction of antigen-specific, antigenpresenting cell-mediated suppression of Th reactivity. Immunol Rev, 2001, 182:201-206.
  • 8Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation in duced bycellular or nonspecific mitogenic stimuli. Blood, 2002, 99:3838-3843.
  • 9Meisel R, Zibert A, Laryea M, et al. Human bone marrow stroreal cells inhibit allogenic T-cell response by indoleamine 2, 3-dioxygenase mediated tryptophan degradation. Blood, 2002, 11:3909-3914.
  • 10Banas RA,Trumpower C,Bentlejewski C,et al.Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells[J].Human Immunol,2008,69(6):321-328.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部